Interrupting the inhibiton of normal hematopoiesis in myelogenous leukemia: a hypothetical approach to therapy.
Lichtman
M A
MA
Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York 14642, USA. mal@urmc.rochester.edu
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001853:Bone Marrow / Q000473:pathology*; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology